RICHARDSON FINANCIAL SERVICES INC.
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 2012303
MEDWAY, MA
Position in VRTX
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$104,313
-$287,302 QoQ
Shares Held
210
-76.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#1,469
of 1,732 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RICHARDSON FINANCIAL SERVICES INC. holds $319,426 across 6 Biotechnology names. VRTX ranks #1 (32.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
210 | $104,313 | |
| 2 | RPRX |
Royalty Pharma plc
|
1,838 | $103,056 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
572 | $44,770 | |
| 4 | EXEL |
Exelixis, Inc.
|
715 | $38,903 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
88 | $27,815 | |
| 6 | ONC |
BeOne Medicines Ltd.
|
2 | $569 |
All Filings in VRTX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $104,313 | 210 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $391,615 | 877 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $431,598 | 952 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $368,924 | 942 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $454,104 | 1,020 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $491,607 | 1,014 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $392,229 | 974 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $449,265 | 966 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $450,907 | 962 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $391,674 | 937 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $242,913 | 597 | Shares | Sole | 2024-03-04 | |
| No filing history on record for this holder in this stock. | ||||||